Skip to main content
[Preprint]. 2024 Jun 3:rs.3.rs-4244833. [Version 1] doi: 10.21203/rs.3.rs-4244833/v1

Extended Table 2a.

Any grade AE during treatment with 2141-V11 by Dose Level

Any-Grade AE n (%) 0.7 mg 2 mg 7.0 mg 10 mg
N 3 3 3 3
Fever* 0 0 3 2
Pain 1 2 2 0
Rigor/Chills* 0 0 1 2
Injection site reaction* 0 1 2 0
Infection 0 2 0 1
Fatigue 0 1 1 0
MyalgiasΦ 0 1 1 0
Dyspnea 0 0 1 1
Anemia 0 0 2 0
RashΦ 0 0 1 0
Nausea 1 0 0 0
Hot flashesΦ 0 1 0 0
Dysphagia 0 1 0 0
Sinus bradycardia 0 0 1 0
Depression 0 0 1 0
*

Treatment related adverse event

Φ

Possibly related to 2141-V11